Long-Term Use of Cannabis Spray Effective in Treating Multiple Sclerosis Spasticity, Says Study

A study published last week by the journal European Neurology has found that the long-term use of Sativex, a spray made from the cannabis plant (one part THC, one part CBD), is effectivesativex1 in treating multiple sclerosis spasticity.

According to researchers, the study’s objective was to “provide long-term data on clinical outcomes, tolerability, quality of life and treatment satisfaction for MSS [multiple sclerosis spasticity] patients receiving nabiximols [Sativex] in routine care.”

Read moreLong-Term Use of Cannabis Spray Effective in Treating Multiple Sclerosis Spasticity, Says Study

New Study Finds Cannabinoids An Effective Treatment For Multiple Sclerosis

A new study published in this month’s issue of the journal European Neurology, and published online by the U.S. National Institute of Health,stock2 has found that Sativex – a medicinal spray made from the cannabis plant – is an effective and safe treatment option for “moderate to severe multiple sclerosis spasticity (MSS)”.

According to researchers: “Nabiximols (Sativex┬«), a cannabinoid-based oromucosal spray, is an add-on therapy for patients with moderate to severe multiple sclerosis spasticity (MSS) resistant to other medications. The primary objective was to provide real-life observational data of clinical experience of nabiximols in contrast to formal clinical trials of effectiveness.”

Read moreNew Study Finds Cannabinoids An Effective Treatment For Multiple Sclerosis